• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义和治疗中度斑块状银屑病:皮肤科医生调查

Defining and treating moderate plaque psoriasis: a dermatologist survey.

作者信息

Knuckles Melissa L F, Levi Eugenia, Soung Jennifer

机构信息

a Department of Dermatology , Richmond , KY , USA.

b Celgene Corporation , Summit , NJ , USA.

出版信息

J Dermatolog Treat. 2018 Nov;29(7):658-663. doi: 10.1080/09546634.2018.1443200. Epub 2018 Mar 22.

DOI:10.1080/09546634.2018.1443200
PMID:29502473
Abstract

PURPOSE

Patients with moderate plaque psoriasis are often undertreated and may experience unsatisfactory clinical outcomes. Undertreatment may stem partly from a lack of consensus on the definition of moderate psoriasis and appropriate treatments for patients with moderate disease severity.

MATERIALS AND METHODS

An online survey was conducted during October 2015 to determine how US dermatologists in the clinical setting define and treat moderate psoriasis.

RESULTS

A total of 150 dermatologists responded to the survey (mean time in practice: 13.5 years). On average, they saw 72 patients with psoriasis per month; 40% of these patients were considered to have moderate psoriasis. Most (95%) reported assessing disease severity based on the percentage of psoriasis-affected body surface area (BSA); 59% also considered location of the affected area. BSA cutoffs used to define moderate psoriasis varied widely (median low and high cutoffs: 5-10%; range: 1-70%). Similarly, wide variation in cutoff ranges was observed for the Psoriasis Area and Severity Index (PASI), Physician Global Assessment (PGA), and Dermatology Life Quality Index (DLQI). Primary therapy comprised biologics (47%), prescription topicals (28%), and oral systemics (18%).

CONCLUSIONS

The current findings indicate lack of consensus surrounding the definition of moderate psoriasis among US dermatologists.

摘要

目的

中度斑块状银屑病患者常常治疗不足,临床结局可能不尽人意。治疗不足部分可能源于对中度银屑病的定义以及中度病情严重程度患者的适当治疗方法缺乏共识。

材料与方法

2015年10月进行了一项在线调查,以确定美国临床皮肤科医生如何定义和治疗中度银屑病。

结果

共有150名皮肤科医生回复了调查(平均执业时间:13.5年)。他们每月平均诊治72例银屑病患者;其中40%的患者被认为患有中度银屑病。大多数(95%)报告根据银屑病累及的体表面积(BSA)百分比评估疾病严重程度;59%还考虑了受累区域的位置。用于定义中度银屑病的BSA临界值差异很大(低临界值和高临界值中位数:5 - 10%;范围:1 - 70%)。同样,银屑病面积和严重程度指数(PASI)、医生整体评估(PGA)和皮肤病生活质量指数(DLQI)的临界值范围也存在很大差异。主要治疗方法包括生物制剂(47%)、处方外用药物(28%)和口服系统药物(18%)。

结论

目前的研究结果表明,美国皮肤科医生对中度银屑病的定义缺乏共识。

相似文献

1
Defining and treating moderate plaque psoriasis: a dermatologist survey.定义和治疗中度斑块状银屑病:皮肤科医生调查
J Dermatolog Treat. 2018 Nov;29(7):658-663. doi: 10.1080/09546634.2018.1443200. Epub 2018 Mar 22.
2
Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists.中度斑块状银屑病治疗中的差距:沙特皮肤科医生的一项调查。
J Family Med Prim Care. 2021 Dec;10(12):4519-4524. doi: 10.4103/jfmpc.jfmpc_1207_21. Epub 2021 Dec 27.
3
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey.皮肤科医生对中度银屑病定义的看法:加拿大中度银屑病调查。
J Drugs Dermatol. 2021 Feb 1;20(2):126-132. doi: 10.36849/JDD.5531.
4
Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).中度至重度斑块状银屑病的治疗模式:一项比利时横断面研究(DISCOVER)的结果
J Dermatolog Treat. 2017 Aug;28(5):394-400. doi: 10.1080/09546634.2016.1255304. Epub 2016 Nov 15.
5
Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.患者报告的结局是银屑病治疗决策的重要组成部分:美国皮肤科医生的离散选择实验调查。
J Am Acad Dermatol. 2019 Jun;80(6):1650-1657. doi: 10.1016/j.jaad.2019.01.039. Epub 2019 Jan 29.
6
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.严重斑块型银屑病患者生物治疗的临床改善和满意度:一项欧洲横断面观察性研究结果。
J Dermatolog Treat. 2013 Jun;24(3):193-8. doi: 10.3109/09546634.2012.697112. Epub 2012 Sep 21.
7
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).银屑病治疗达标:利用一项基于人群的真实世界队列研究(英国皮肤科医师协会生物制剂和免疫调节剂登记处,BADBIR)的数据定义银屑病的治疗结果
Br J Dermatol. 2020 May;182(5):1158-1166. doi: 10.1111/bjd.18333. Epub 2019 Sep 10.
8
The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.三种银屑病评估工具的可靠性:银屑病面积和严重程度指数、体表面积和医师整体评估。
Adv Clin Exp Med. 2017 Aug;26(5):851-856. doi: 10.17219/acem/69804.
9
Moderate Psoriasis: A Proposed Definition.中度银屑病:一个拟议的定义。
Actas Dermosifiliogr. 2017 Dec;108(10):911-917. doi: 10.1016/j.ad.2017.07.002. Epub 2017 Aug 17.
10
Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.对当前银屑病治疗的满意度:医生与患者认知之间的差异
Dermatol Online J. 2016 Jul 15;22(7):13030/qt7405k1nn.

引用本文的文献

1
Latin American consensus on psoriasis severity classification.拉丁美洲银屑病严重程度分类共识。
An Bras Dermatol. 2025 May-Jun;100(3):539-547. doi: 10.1016/j.abd.2024.09.010. Epub 2025 Apr 29.
2
Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion.中度银屑病关节炎定义中应包含的核心项目:文献回顾和专家意见。
Rheumatol Int. 2024 Nov;44(11):2327-2336. doi: 10.1007/s00296-024-05644-y. Epub 2024 Jul 6.
3
Topically applied pH-responsive nanogels for alkyl radical-based therapy against psoriasiform hyperplasia.
用于烷基自由基治疗银屑病样增生的局部应用 pH 响应性纳米凝胶。
Drug Deliv. 2023 Dec;30(1):2245169. doi: 10.1080/10717544.2023.2245169.
4
Current knowledge of the implication of lipid mediators in psoriasis.脂质介质在银屑病中的作用的最新认识。
Front Immunol. 2022 Aug 26;13:961107. doi: 10.3389/fimmu.2022.961107. eCollection 2022.
5
Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists.中度斑块状银屑病治疗中的差距:沙特皮肤科医生的一项调查。
J Family Med Prim Care. 2021 Dec;10(12):4519-4524. doi: 10.4103/jfmpc.jfmpc_1207_21. Epub 2021 Dec 27.
6
The Use of Metrics in Daily Practice and the Perception of Psoriasis-Associated Comorbidities: Discrepancies Between Research and Real-World.日常实践中指标的使用以及对银屑病相关合并症的认知:研究与现实世界之间的差异
Psoriasis (Auckl). 2021 Dec 21;11:169-175. doi: 10.2147/PTT.S341215. eCollection 2021.
7
Copy Number Variation Analysis of IL22 and LCE3C in Different Subtypes of Psoriasis in a Chinese Han Population.中国汉族人群不同类型银屑病中 IL22 和 LCE3C 的拷贝数变异分析。
Med Sci Monit. 2021 Dec 2;27:e934927. doi: 10.12659/MSM.934927.
8
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients.中重度银屑病:卡泊三醇倍他米松二丙酸酯泡沫剂用于成人患者局部治疗的共识声明
Dermatol Ther (Heidelb). 2021 Oct;11(5):1791-1804. doi: 10.1007/s13555-021-00600-1. Epub 2021 Sep 12.
9
A New Classification of the Severity of Psoriasis: What's Moderate Psoriasis?银屑病严重程度的新分类:什么是中度银屑病?
Life (Basel). 2021 Jun 29;11(7):627. doi: 10.3390/life11070627.
10
Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells.无临床明显心血管疾病的斑块状银屑病和银屑病关节炎患者的心血管风险:内皮祖细胞的作用
Postepy Dermatol Alergol. 2020 Jun;37(3):299-305. doi: 10.5114/ada.2020.96085. Epub 2020 Jul 14.